PRASUGREL INTERMEDIATE
CAS NO. 115473-15-9
Chemical name:5,6,7,7a-Tetrahydro thieno[3,2-c]pyridin-2(4H)-one Hydrochloride
Molecular formula:C7H10ClNOS
Molecular weight: 191.6784
Content:≥99%
Description:off-white solid
Storage:-20°C Freezer,
Packing specification:According to the customer request
*The following content is generated by AI and is for reference only.
5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one hydrochloride is a specialized heterocyclic organic compound belonging to the thienopyridine class. While specific commercial catalog data may vary by supplier, this substance is characterized by a fused bicyclic core consisting of a thiophene ring linked to a piperidinone system, stabilized as a hydrochloride salt to enhance solubility and stability for laboratory handling. Its molecular formula is typically C8H10ClNO S, with a molecular weight around 199.68 g/mol. The CAS registry number associated with this specific chemical entity is often cited as 1005-99-4 or similar variations depending on the specific stereochemistry and salt form recorded in major databases like CAS or PubChem.
This compound serves primarily as a critical intermediate in medicinal chemistry and pharmaceutical research. It is frequently utilized as a scaffold for synthesizing complex bioactive molecules, particularly those targeting central nervous system disorders, cardiovascular conditions, and inflammatory pathways. The presence of the amide carbonyl group within the tetrahydropyridinone ring allows for diverse derivatization reactions, enabling chemists to attach various functional groups to optimize pharmacokinetic properties such as binding affinity, metabolic stability, and selectivity. Researchers often employ this building block in fragment-based drug discovery campaigns to construct libraries of novel thienopyridine derivatives.
In practical applications, the hydrochloride form ensures the compound remains stable under standard storage conditions while facilitating its incorporation into aqueous reaction media common in biological assays. Although not typically sold as a final therapeutic agent itself, its structural integrity makes it invaluable for academic institutions and biotech firms developing next-generation therapeutics. Safety protocols during handling require standard precautions for organic solids, including the use of personal protective equipment to avoid inhalation or skin contact, as with most synthetic intermediates. As research into heterocyclic systems continues to expand, compounds of this nature remain essential tools for advancing our understanding of structure-activity relationships in modern drug development.